marcus evans europe conferences

16th Annual Strategic Project & Portfolio Management for Pharma

Build a Solid Portfolio Infrastructure to Adapt to Changes and Prevent Risks, Proceed with the Right Decision, Maximize Value under Tight Budget and Resources, Develop Synergies and Opportunities on New Markets.

25-27 January 2017
Barcelona, Spain

Why You Should Attend

16th Annual Strategic Project & Portfolio Management for Pharma

As the strategic and operating environment for Pharmaceutical R&D becomes more cost-constrained and evolving portfolios require increasingly more investment, critical decision-making and methodology is evidently a crucial element in PPM.

The conference will look at how to structure portfolio management into the organization, how to transform R&D indicators and PPM parameters into successful revenue producing projects and portfolios that align corporate business goals. This year approach will be both on technical side, on understanding how right processes, realistic analysis and correct interpretation of data can be translated into market success; but also how organizational aspects, how capacity management, leadership skills can build high performing teams and strategic decision making.

Importantly, this conference will not neglect the other essential topics including prioritisation, internal resource management, risk management and especially de-risking strategies (partnerships, outsourcing) as main factor of market success, managing pipeline from early stage to commercial stage, with a view on market access and generic portfolio management.

Key Topics

  • Gain practical methodology to implement efficiently portfolio management
  • Maximise portfolio value under limited budgets
  • Benefit from early stage decision making
  • Link portfolio decisions to market development
  • Balance internal investments with external resources and partnerships
  • Previous Attendees Include

    Abbott Products Operations Ag
    Abdi Ibrahim Ilac San. Ve. Tic. A.S.
    Alkermes Pharma Ireland Limited
    Almirall Hermal GmbH
    Astra Zeneca
    Baxter Global Marketing
    Bayer Pharma AG
    Biotest AG
    Boehringer Ingelheim
    Cylad Consulting
    Daiichi-Sankyo Development Ltd.
    F.Hoffman-La Roche AG
    Fresenius Kabi Deutschland
    Janssen Pharmaceutica
    Janssen Research & Development
    Jerusalem Pharmaceuticals Company
    Jerusalem Pharmaceuticals Company
    LFB Biotechnologies
    Medac GmbH
    Merck Group
    Mundipharma Research
    Pierre Fabre Pharmaceutical Health Care
    Teva Pharmaceuticals
    Vifor Pharma

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Voice of Our Customers
    • “The conference is well organised and speakers are all high quality!” Programme Coordinator, J&J
    • “High quality speakers, enjoyed the networking” VP, Debiopharm
    • “I appreciated the conference a lot, having the possibility to compare project management actions of my company with the other companies” Project Manager R&D, Chiesi
    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Melini Hadjitheori

    PO Box 24797
    CY-1304 Nicosia

    +357 22 849 308
    Fax: +357 22 849 394